A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.
New York Times
By BY MIHIR ZAVERI AND KATIE THOMAS from NYT Health https://ift.tt/31YDhZP
October 8, 2019 at 03:47PM
A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.
New York Times
By BY MIHIR ZAVERI AND KATIE THOMAS from NYT Health https://ift.tt/31YDhZP
October 8, 2019 at 03:47PM
No comments:
Post a Comment